Subscribe Now Advertise

Categories

search Result

Indian pharma sector poised for 8-10% growth this fiscal: CRISIL

Following a successful year with approximately 10% growth, the outlook is bolstered by easing pricing pressures in the US generics market and improved operating leverage, which is expected to raise operating margins by 70-80 basis points to around 22.5%. Read more

Nearly 2,000 drug manufacturing plants overdue for FDA inspections post-COVID

These overdue inspections affect about 42% of the 4,700 registered drug manufacturing plants that were reviewed by the FDA before May 2019.Read more

Over 1,300 units operational under PLI scheme; to generate jobs

Preliminary calculations suggest that the production of Rs 10 trillion under the PLI scheme should translate to incentives worth Rs 500 billion.Read more

Pharma firms ask for December 2026 as extension for implementation of rules

Schedule M of the Drugs and Cosmetics Rules, 1945, outlines good manufacturing practices (GMP) for pharmaceutical products, including a prompt recall system for defective products.Read more

New scheme to strengthen India’s medical device industry to launch soon

Additionally, the Union Cabinet's approval of the National Medical Devices Policy last April is expected to further drive growth in the sector.Read more

USFDA sends warning to Eugia over manufacturing violations at Telangana facility

The regulatory body noted that Eugia failed to maintain complete laboratory records essential for compliance with established specifications and standards.Read more

Vishnu Chemicals acquires Jayansree Pharma in Rs 520 million deal

Vishnu Chemicals is set to buy 100% of JPPL’s shares within the next three months.Read more

Indian pharma exports surge with 8.36% growth in July 2024

The Indian pharmaceutical industry is projected to grow to $65 billion by 2024 and to $130 billion by 2030. Read more

DCGI introduces guidelines for product traceability in pharma supply chain

The introduction of these guidelines is particularly timely, as the Indian pharmaceutical industry has come under scrutiny following reports linking spurious cough syrups from India to children's deaths in Gambia, Cameroon, and Uzbekistan.Read more

India’s API industry expected to grow 7-8% in FY25

The operating profit margin (OPM) is forecasted to rise to 12-14%, up from 11-13% in the previous fiscal year.Read more

Hi There!

Now get regular updates from IPF Magazine on WhatsApp!

Click on link below, message us with a simple hi, and SAVE our number

You will have subscribed to our Industrial News on Whatsapp! Enjoy

+91 84228 74016